We are please to advise that the OFFICE OF DRUG CONTROL has now approved LeafCann’s CANNABIS RESEARCH LICENCE and MEDICINAL CANNABIS LICENCE (Cultivation) for a period of three years. This is in addition to LeafCann’s existing NARCOTIC MANUFACTURING LICENCE (Cannabis).

The LeafCann mission is to advance the re-introduction of plant-based extracts in medicine and nutrition through conducting and supporting product and industry research and development, clinical trials, commercial production and GMP manufacturing. 

LeafCann is building a robust and agile Medicinal Cannabis supply chain, forging export agreements and working towards ensuring patients have access to precision cannabis medicines made from the highest quality ingredients at affordable prices.

 

CULTIVATION

Creating a new agricultural industry with a focus on genetic acquisition and breeding new medicines for the Australian medicinal cannabis market.  

LC 361 2016_Web Design 1_graph42.jpg

MANUFACTURE

LeafCann will produce a range of Activated Pharmaceutical Ingredients (APIs), including whole plant extracts, bespoke extracts and isolates, and finished products under GMP.

RESEARCH

Facilitate a range of diverse research initiatives , including: Genetics development, Agriculture & Horticulture, Extraction processes and product formulation and development. 

PATIENT ACCESS

The LeafCann ethos of Patient before Profit will ensure our customers are well educated and safe, with access to quality products at an affordable price. 

 

At LeafCann we want to give patients a constant, easy to access supply of the highest quality medical cannabis products.

That’s why we spent a lot of time researching the best controlled environment GMP Indoor production, complemented by GACP Greenhouse partners.

So how does it work? LeafCann’s production methodology simulates ideal growing conditions for each cultivar to support expression of key cannabinoids, terpenes and other plant molecules in the desired ratios, resulting in high quality, safe and effective end products.

That’s great news for patients and investors because it means that LeafCann will be able to deliver a high quality product at a price that’s fair for everyone. 

 

 



 

THE ‘SEED TO SALE’ PROCESS

LC 361_Web Design Assets_GraphicSeedToSale.jpg